Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cardiovascular
Biomarker, tissue study shows body composition in patients treated with Ozempic
By
Liz Carey
Artificial intelligence tools may aid healthcare teams in monitoring the negative impacts of weight loss and diabetes drugs.
September 20, 2024
Rapid blood test for heart attack holds promise for shorter ED stays
By
LabPulse.com staff writers
A rapid blood test that can distinguish heart attack in people presenting at emergency departments (EDs) with chest pain has been developed by researchers.
September 5, 2024
Johnson & Johnson to acquire V-Wave for up to $1.7B
By
LabPulse.com staff writers
Johnson & Johnson has entered a definitive agreement to buy V-Wave, a developer of cardiovascular implant technology.
August 20, 2024
At-home heart failure screening device unveiled at ACS meeting
By
LabPulse.com staff writers
A prototype heart-failure screening device that measures levels of two biomarkers for heart failure in as little as 15 minutes from a drop of saliva is being presented at the American Chemical Society (ACS) hybrid fall meeting.
August 20, 2024
Molecular testing studied for remote post-transplant care
By
Liz Carey
Using combined molecular testing to monitor heart transplant patients for allograft injury is better than using either test alone and could support remote testing in post-transplant care, according to data gathered by the SHORE registry.
May 21, 2024
Boston Scientific gets FDA approval for drug-coated balloon catheter
By
LabPulse.com staff writers
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent drug-coated balloon, a paclitaxel-coated balloon catheter sized to fit within blocked or constricted coronary arteries to treat coronary in-stent restenosis.
March 4, 2024
International consortium aims to develop precision approach for CVD
By
Matt Limb
An international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.
February 21, 2024
Abbott begins clinical development of a pulsed field ablation device
By
Nick Paul Taylor
Abbott has begun clinical development of a pulsed field ablation (PFA) device that could rival Boston Scientific, Johnson & Johnson, and Medtronic for an emerging atrial fibrillation (AFib) market.
January 24, 2024
High-sensitivity assay improves diagnosis for patients with heart muscle injury in U.K. study
By
Matt Limb
A high-sensitivity blood test can improve diagnosis for 1 in 5 patients who have a heart muscle injury, according to a U.K. hospital study.
December 6, 2023
Potential drug target to prevent small vessel disease identified in study
By
Matt Limb
Scientists say lab-grown small blood vessels used in new disease models point to a theoretical potential treatment for a major cause of stroke and vascular dementia.
November 29, 2023
AI-powered blood test supports risk stratification of heart disease patients
By
Nick Paul Taylor
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
AI concurs with humans in heart failure test, suggesting scalable approach to clinical trials
By
Nick Paul Taylor
Artificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.
November 21, 2023
Page 1 of 8
Next Page
